U.S. Large Molecule Drug Substance CDMO Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Biologics, Biosimilar), By Service (Contract Manufacturing, Contract Development), By Source, By End Use, By Country, And Segment Forecasts
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
Table of Contents
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Service
1.2.3. Source
1.2.4. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Botton-Up Approach
1.7.4. Multivariate Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Large Molecule Drug Substance CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Industry Analysis Tools
3.6.1. Porter’s Five Force Analysis
3.6.2. PESTEL by SWOT Analysis
Chapter 4. U.S. Large Molecule Drug Substance CDMO Market: Product Estimates & Trend Analysis
4.1. U.S. Large Molecule Drug Substance CDMO Market, By Product: Segment Dashboard
4.2. U.S. Large Molecule Drug Substance CDMO Market, By Product: Movement Analysis
4.3. U.S. Large Molecule Drug Substance CDMO Market Estimates & Forecasts, By Product, 2021 - 2033 (USD Million)
4.4. Biologics
4.4.1. Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Biosimilar
4.5.1. Biosimilar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Large Molecule Drug Substance CDMO Market: Service Estimates & Trend Analysis
5.1. U.S. Large Molecule Drug Substance CDMO Market, By Service: Segment Dashboard
5.2. U.S. Large Molecule Drug Substance CDMO Market, By Service: Movement Analysis
5.3. U.S. Large Molecule Drug Substance CDMO Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
5.4. Contract Manufacturing
5.4.1. Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2. Clinical
5.4.2.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3. Commercial
5.4.3.1. Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Contract Development
5.5.1. Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.2. Cell Line Development
5.5.2.1. Cell Line Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.3. Process Development
5.5.3.1. Process Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Large Molecule Drug Substance CDMO Market: Source Estimates & Trend Analysis
6.1. U.S. Large Molecule Drug Substance CDMO Market, By Source: Segment Dashboard
6.2. U.S. Large Molecule Drug Substance CDMO Market, By Source: Movement Analysis
6.3. U.S. Large Molecule Drug Substance CDMO Market Estimates & Forecasts, By Source, 2021 - 2033 (USD Million)
6.4. Mammalian
6.4.1. Mammalian Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Microbial
6.5.1. Microbial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Others
6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Large Molecule Drug Substance CDMO Market: End Use Estimates & Trend Analysis
7.1. U.S. Large Molecule Drug Substance CDMO Market, By End Use: Segment Dashboard
7.2. U.S. Large Molecule Drug Substance CDMO Market, By End Use: Movement Analysis
7.3. U.S. Large Molecule Drug Substance CDMO Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
7.4. Biotech Companies
7.4.1. Biotech Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. CRO
7.5.1. CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Others
7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Key Participant Categorization
8.1.1. Market Leaders
8.1.2. Emerging Players
8.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
8.3. Company Profiles
8.3.1. Eurofins Scientific
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. WuXi Biologics
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Samsung Biologics
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Catalent, Inc.
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Rentschler Biopharma SE
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. AGC Biologics
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Recipharm AB
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Siegfried Holding AG
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Boehringer Ingelheim
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. FUJIFILM Diosynth Biotechnologies
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 4 U.S. Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 5 U.S. Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 6 U.S. Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 Large Molecule Drug Substance Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 U.S. Large Molecule Drug Substance CDMO Market: Product outlook and key takeaways
Fig. 20 U.S. Large Molecule Drug Substance CDMO Market: Product movement analysis
Fig. 21 Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 22 Biosimilar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 23 U.S. Large Molecule Drug Substance CDMO Market: Service outlook and key takeaways
Fig. 24 U.S. Large Molecule Drug Substance CDMO Market: Service movement analysis
Fig. 25 Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 26 Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 27 Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 28 Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 29 Cell Line Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 30 Process Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 31 U.S. Large Molecule Drug Substance CDMO Market: Source outlook and key takeaways
Fig. 32 U.S. Large Molecule Drug Substance CDMO Market: Source movement analysis
Fig. 33 Mammalian Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 34 Microbial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 35 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 36 U.S. Large Molecule Drug Substance CDMO Market: End Use outlook and key takeaways
Fig. 37 U.S. Large Molecule Drug Substance CDMO Market: End Use movement analysis
Fig. 38 Biotech Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 39 CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 40 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 41 Key company categorization
Fig. 42 Service heat map analysis
Fig. 43 Strategic framework
Get Free Sample Report
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
